4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001725092-26-000004
Options or other derivatives
- Chief Executive Officer bought 136,359 shares at $11.00 ($999,966)
From the SEC's structured data for this filing
Trades in this filing
Lin Shao-Lee · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-01 | Purchase : show line 1 in the form Pre-Funded Warrants (Right to Buy) | +90,906 | $11.00 | $999,966 | 90,906 | I |
| 2026-06-01 | Purchase : show line 2 in the form Common Stock Warrants (Right to Buy) | +45,453 | 45,453 | I |
Loading xslF345X06/form4-06032026_090611.xml…